Skip to search formSkip to main contentSkip to account menu

arbekacin sulfate

Known as: D-streptamine, O-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1->6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1->4))-N1-((2S)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, sulfate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Arbekacin (ABK) is an aminoglycoside and widely used in Japan for treatment of patients infected with methicillin-resistant… 
2013
2013
We assessed the safety and pharmacokinetics of arbekacin sulfate (ABK, brand name: Habekacin injection) in single and 7-day… 
2012
2012
The efficacy and safety of once-daily high-dose arbekacin sulfate therapy for methicillin-resistant Staphylococcus aureus (MRSA… 
2009
2009
BACKGROUND A case of methicillin-resistant Staphylococcus aureus (MRSA)-pyomyositis in association with acute myelogenous… 
2008
2008
The track records of the use of anti-methicillin-resistant Staphylococcus aureus agents (anti-MRSA agents) in a 5-year period… 
2002
2002
Abstract. We developed a calcium phosphate cement containing arbekacin sulfate and polylactic acid (CPC95AP) and examined its… 
2002
2002
To the Editor: A 43-year-old Japanese female patient suffering from CREST syndrome came to our clinic with a refractory cutaneous… 
1995
1995
A novel drug delivery system for osteomyelitis was developed using porous hydroxyapatite blocks (HA-b) loaded with antibiotics by… 
1994
1994
UNLABELLED A clinical investigation was carried out to evaluate arbekacin, an aminoglycoside, in the treatment of MRSA infections… 
1994
1994
Arbekacin sulfate (ABK) was administered by intravenous drip to pneumonia patients infected with methicillin-resistant…